Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder.

Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.

All told, who took GLP-1 receptor agonists had a 7% lower risk of developing an OAC – which include cancers of the oesophagus, colon, rectum, stomach, liver, gallbladder, pancreas, kidney, post ...

Officials say common weight loss and diabetes management drugs, known as GLP-1 receptor agonists, have become very popular nationwide, sold as Mounjaro, Zepbound, Ozempic, and Wegovy.

Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...